Patients who are under hemodialysis due to end stage renal disease
Patients who have resistant hypertension with office SBP \>160 mmHg)
Patients who are or over 18 years old.
Patients who submit informed consent
You may not be if
Known secondary hypertension patients
Patients who have renal artery which is not adequate for renal denervation
1. The main renal artery diameter \< 4 mm, or renal artery length \< 20 mm
2. The renal arteries into which stable catheter insertion is difficulty and which have hemodynamically or anatomically significant stenosis
3. The renal arteries who have undergone renal angioplasty
Patients who have history of myocardial infarction, unstable angina, syncope cerebrovascular insufficiency or extensive atherosclerotic disease with intravascular thrombosis, or unstable plaque
Type 1 Diabetes
Patients who have scheduled percutaneous coronary intervention (PCI) or operation within 6 months
Hemodynamically significant valvular heart disease in which blood pressure reduction may cause significant deterioration of patient's health.
Primary pulmonary hypertension
Patients who have the intracardiac defibrillator(ICD) or pacemaker which do not allow delivery of radiofrequency energy.
Patients who require continuous oxygen supply or mechanical ventilation for treatment of obstructive sleep apnea
Patients who have serious medical condition which can compromise the safety of the patients and the safety and integrity of the study.
Patients who have unresolved drug issue, alcoholism
Patients who lack ability to understand and follow the instruction the researcher
Patient who cannot follow up
Patients who are registered in other trial
Patients who are pregnant, nursing or planning to be pregnant
Clareo Health | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension
